CME GROUP INC CLASS A (CME) Stock Forecast & Price Prediction

Data as of 2026-09-12 · Financials sector.

Forecast: StoQuant's ML model estimates a 39% probability that CME GROUP INC CLASS A (CME) outperforms the S&P 500 over the forecast period — a bearish signal. Wall Street's consensus 12-month price target is $309.50 from 8 analyst targets.

ML Forecast

39% bearish

Probability of beating the S&P 500 over the forecast period

Q-Score

54/100

Grade C — "Hold" composite of 140+ signals

Analyst Target

$309.50

8 targets · $293.00–$330.00

Next Earnings

2026-10-28

in 45 days — expect volatility

What Wall Street is saying about CME

Across 8 price targets published in the last 90 days (latest 2026-08-16), the consensus for CME GROUP INC CLASS A is $309.50 — spanning $293.00 on the low end to $330.00 on the high end.

Next-period consensus: EPS n/a (as of 2030-12-31).

Recent rating changes

Keefe, Bruyette & Woods upgraded from Market Perform to Outperform (2026-06-18)

Track record — don't trust a forecast without one

StoQuant publishes its full walk-forward accuracy, updated daily. Current hit rates across all scored signals:

Signal	Window	Hit rate	Avg return	Observations
Fundamental Undervalue	7d	51.1%	+0.50%	9,340
Vc Intelligence	7d	50.0%	+0.72%	18
Volume Spike	7d	49.1%	+0.23%	6,275
Sector Momentum	7d	48.5%	+0.02%	16,414

See the full live track record → · How the model works

⚠ CME GROUP INC CLASS A reports earnings on 2026-10-28 — expect elevated volatility and a forecast refresh right after the report.

Peers & alternatives

Similar stocks to CME for comparison and diversification research:

HSBC research RY research MUFG research TD research SAN research

Compare CME vs HSBC head-to-head →

More forecasts to explore

AAPL MSFT NVDA GOOGL GOOG AMZN META TSLA AVGO LLY JPM V WMT XOM UNH MA COST ORCL HD NFLX

Explore more forecasts

Discover other stocks and tools:

All forecasts Free screener Full CME research Proof & methodology

CME forecast FAQ

What is the CME stock forecast?

StoQuant's ML model estimates a 39% probability that CME GROUP INC CLASS A (CME) outperforms the S&P 500 over the forecast period — a bearish signal. Wall Street's consensus 12-month price target is $309.50 from 8 analyst targets.

Is CME stock a buy or sell right now?

StoQuant's Q-Score rates CME 54/100 (grade C, "Hold") and the ML signal is bearish at 39% probability. StoQuant publishes its full walk-forward track record at /proof — always check a forecaster's accuracy before acting.

What is the analyst price target for CME?

The consensus analyst price target for CME GROUP INC CLASS A is $309.50, with a range of $293.00 to $330.00 across 8 recent analyst targets.

How accurate are StoQuant's stock forecasts?

Across StoQuant's walk-forward validated signal history, the fundamental undervalue signal hit its 7-day target in 51.1% of 9,340 observations (avg return +0.50%). Full methodology and live accuracy at /proof.

When does CME report earnings?

CME GROUP INC CLASS A is scheduled to report earnings on 2026-10-28. Expect elevated forecast volatility around the report.

More stock forecasts in this sector

Technology sector forecasts

MSFT · AAPL · NVDA · GOOGL · META · TSLA · AMD · INTC · QCOM · AVGO

Large-cap diversified forecasts

BRK.B · JPM · V · MA · WMT · PG · JNJ · XOM · UNH · HD

Consumer and healthcare forecasts

COST · MCD · NFLX · DIS · PFE · ABBV · TMO · CRM · ADBE

Financial and energy forecasts

BAC · WFC · GS · MS · CVX · COP · UBER · AMAT · MU

Get CME's forecast refreshed daily — plus the full signal stack.

ML forecasts, Q-Scores, insider clusters, and catalysts across 4,000+ tickers. Free screener.

Open the free screener Full CME research

Additional resources

Track record · Methodology · All forecasts · CME deep dive

Forecasts are probabilistic model outputs, not investment advice. Past accuracy does not guarantee future results.